麻豆传媒

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

FDA EUA pemivibart (Pemgarda) over a computer rendering of antibodies attacking COVID viruses.

New Monoclonal Authorized to Prevent COVID in Immunocompromised People

No such option has been available since FDA revoked the authorization of Evusheld last year

A computer rendering of the lymphatic system in a female body

Study Shows Feasibility, Safety of Omitting Axillary Surgery in Early Breast Cancer

Pathologic CR to guide treatment decisions led to similar outcomes in node-positive disease

A photo of Kate, the Princess of Wales

Kate Middleton Has Cancer

Princess of Wales is undergoing chemotherapy

FDA APPROVED ponatinib (Iclusig) over a computer rendering of the destruction of lymphoblast cells

FDA Approves New Frontline Regimen for Aggressive ALL

Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases

A photo of proposed cigarette warning labels.

Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules

Partial victory for federal regulators seeking to toughen warning labels

Onco Break over a computer rendering of a cancer cell.

Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer

News, features, and commentary about cancer-related issues

A photo of a female radiologist discussing the radiotherapy treatment plan with her female patient.

Low-Dose RT Boost Wins Support for Young Patients With Early Breast Cancer

A 1.6% reduction in locoregional recurrence with higher dose offset by worse cosmetic outcomes

A photo of radiologists prepping a linear accelerator for their next patient.

No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation

PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Child Deaths Rise in U.S.; Water Beads Warning; Cancer Studies Retracted

Health news and commentary from around the Web gathered by 麻豆传媒 staff

A screenshot of Michael Witt speaking during this hearing.

Who Should Pay to Clean Up 'Forever Chemicals'?

Not us, representatives of water utilities and landfills say at a Senate hearing

A computer rendering of prostate cancer.

Mutation Linked to Increased Risk of Prostate Cancer Mortality

Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele

SGO over a photo of San Diego Convention Center in San Diego, CA

Lenvatinib-Pembrolizumab Combo Misses on Survival in Endometrial Cancer Trial

Combination in first-line fails to improve progression-free, overall survival versus chemotherapy

A photo of a woman reading a book while receiving chemotherapy

Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin

Dose-dependent increase regardless of age at treatment or chest radiotherapy

SGO over a photo of San Diego Convention Center in San Diego, CA

Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer

Use of the PARP inhibitor improved PFS by 19.4 months versus placebo in phase II study

A photo of Asbestos Removal Technologies Inc. staff working to remove asbestos from a home in Howell, Michigan.

EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban

New rule would prohibit chrysotile asbestos

SGO over a photo of San Diego Convention Center in San Diego, CA

Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence

Growing body of data suggest it can be safe and effective in low-risk disease, says expert

SGO over a photo of San Diego Convention Center in San Diego, CA

Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesions

Response rate doubles with the noninvasive treatment versus placebo

A photo of a senior woman receiving a covid vaccination from a female nurse.

How Often Should Immunocompromised People Get a COVID Booster?

Experts say about every 6 months, but that should be individualized

SGO over a photo of San Diego Convention Center in San Diego, CA

Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs

Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says

SGO over a photo of San Diego Convention Center in San Diego, CA

Laparoscopy Quickly Abandoned in Early Cervical Cancer After LACC Results

MIS roughly halved in the 2 years following the study results, national dataset shows

SGO over a photo of San Diego Convention Center in San Diego, CA

Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer

Dostarlimab and pembrolizumab regimens should be incorporated into practice "as of yesterday"

SGO over a photo of San Diego Convention Center in San Diego, CA

Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer

Novel ADC targeting CDH6 achieves response in nearly 50% of patients

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma

Cilta-cel, ide-cel win support despite concerns about early mortality risk

Delta-8 THC Use Common in Teens; New Drug-Coated Balloon for Blocked Stents

Also in TTHealthWatch: new screening methods for colorectal cancer

A photo of a woman holding a tray of stainless equipment at a medical sterilization facility

EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk

Rule would lower emission standards for ethylene oxide by 90%, agency says

FDA APPROVED lisocabtagene maraleucel (Breyanzi) over a computer rendering of CLL cells in the blood stream.

FDA Approves First CAR-T for Chronic Lymphocytic Leukemia

Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL

FDA APPROVED tislelizumab (Tevimbra) over a computer rendering of esophageal cancer.

New PD-1 Inhibitor Approved for Esophageal Cancer

Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

FDA Panel Endorses Imetelstat for MDS-Related Anemia

By 12-2 vote, members find improvement in transfusion independence outweighs risk

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma

FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting

Onco Break over a computer rendering of a cancer cell.

Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'

News, features, and commentary about cancer-related issues

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Rheumatologist Found Dead; How COVID Changed Lives; Olivia Munn's Breast Cancer

Health news and commentary from around the Web gathered by 麻豆传媒 staff

A photo of Olivia Munn arriving at Chanel鈥檚 15th Annual Pre-Oscar Awards Dinner.

Olivia Munn Reveals Breast Cancer Diagnosis and Double Mastectomy

A high Breast Cancer Risk Assessment Score led to imaging and a biopsy

An MRI image of a glioblastoma

Novel CAR-T for Glioblastoma Induced 'Dramatic' Responses in Early Trial

In three patients, one-time infusion of CARv3-TEAM-E T cells resulted in rapid tumor regression

A computer rendering of tumors in the colon.

Noninvasive Screening Tests Show Promise for Catching Colorectal Cancer

Could these tests help to increase the number of people who undergo screening?

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

A computer rendering of sickle cells in the bloodstream

Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recs

Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain

A photo of a female virologist marking samples with a marker in a laboratory.

Banning Gain-of-Function Research Would Do Far More Harm Than Good

A House-passed bill could stifle the potential for revolutionary medical advancements

A photo of a young male physician in his office talking to his senior male patient

Knowing When to Start, Knowing When to Stop

Discussions about screening recommendations can be difficult, but they're worth having

FDA APPROVED nivolumab (Opdivo) over a computer rendering of bladder cancer.

First-Line Nivolumab Plus Chemo Approved for Bladder Cancer

Combination reduced risk of death by 22%

A photo of a senior man receiving chemotherapy.

First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests

Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy

鈥�

15

鈥�